로딩 중…
지수 로딩 중…
Nuvation Bio Inc.
NUVB· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$5.54+3.94%
2026-06-18
Price Chart
Nuvation Bio Inc.+209.50%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.93B |
| Revenue | $143M |
| Net Income | $-146M |
| Total Assets | $610M |
| Net Assets | $320M |
| Value | |
| P/B | 6.04x |
| P/S | 13.49x |
| FCF Yield | -6.53% |
| Profitability | |
| ROE | -45.69% |
| ROA | -23.92% |
| Op. Margin | -104.99% |
| Revenue Growth | 2598.70% |
| Financial Health | |
| Debt Ratio | 90.96% |
| Total Debt | $10M |
| FCF | $-126M |
| Cash | $125M |
| Current Ratio | 7.44x |
| Performance | |
| 1Y Return | 209.50% |
| 1M Return | 30.66% |
| From 52W High | -43.18% |
| 1Y MDD | -57.55% |
| Trading | |
| Volume | 3,705,571 shares |
| Trading Value | $20M |
| Per Share | |
| EPS | $-0.59 |
| BPS | $0.89 |